High-mobility group box 1 protein blockade suppresses development of abdominal aortic aneurysm.

[1]  M. Akaike,et al.  Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability. , 2011, Journal of cardiology.

[2]  Y. Okada,et al.  Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. , 2011, Atherosclerosis.

[3]  M. Moskowitz,et al.  High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral Ischemia , 2010, Stroke.

[4]  Gene Kim,et al.  S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm , 2010, Circulation research.

[5]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2010, Nature.

[6]  H. Shimomura,et al.  Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction. , 2009, Journal of cardiology.

[7]  K. Kent,et al.  Anti-Receptor for Advanced Glycation End Products Therapies as Novel Treatment for Abdominal Aortic Aneurysm , 2009, Annals of surgery.

[8]  S. Yamada,et al.  Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. , 2008, Cardiovascular research.

[9]  P. Tsao,et al.  Circulating markers of abdominal aortic aneurysm presence and progression. , 2008, Circulation.

[10]  T. Yoshino,et al.  Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  M. Nobuyoshi,et al.  HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. , 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[12]  Haichao Wang,et al.  Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.

[13]  N. Weintraub,et al.  Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Maseri,et al.  Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  J. Golledge,et al.  Atvb in Focus Abdominal Aortic Aneurysms: Pathophysiological Mechanisms and Clinical Implications Abdominal Aortic Aneurysm Pathogenesis and Implications for Management , 2022 .

[16]  D. Milewicz,et al.  Pathogenesis of Thoracic and Abdominal Aortic Aneurysms , 2006, Annals of the New York Academy of Sciences.

[17]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[18]  E. Abraham,et al.  Anti-High-Mobility Group Box Chromosomal Protein 1 Antibodies Improve Survival of Rats with Sepsis , 2006, World Journal of Surgery.

[19]  R. Ricci,et al.  Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.

[20]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[21]  N. Kalinina,et al.  Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines , 2004 .

[22]  M. Aoki,et al.  Inhibition of Experimental Abdominal Aortic Aneurysm in the Rat by Use of Decoy Oligodeoxynucleotides Suppressing Activity of Nuclear Factor &kgr;B and ets Transcription Factors , 2003, Circulation.

[23]  N. Kalinina,et al.  Lesions : Role of Activated Macrophages and Cytokines Increased Expression of the DNA-Binding Cytokine HMGB 1 in Human Atherosclerotic , 2004 .

[24]  P. Kitslaar,et al.  Serum C-Reactive Protein Level Is Associated With Abdominal Aortic Aneurysm Size and May Be Produced by Aneurysmal Tissue , 2003, Circulation.

[25]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[26]  K. Angquist,et al.  Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[27]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[28]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[29]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[30]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[31]  M. Leinonen,et al.  Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.